Follicle-stimulating hormone peptide-conjugated nanoparticles for targeted shRNA delivery lead to effective gro-α silencing and antitumor activity against ovarian cancer

• Үндсэн зохиолчид: Shan-Shan Hong (Зохиогч), Ming-Xing Zhang (Зохиогч), Meng Zhang (Зохиогч), Yi Yu (Зохиогч), Jun Chen (Зохиогч), Xiao-Yan Zhang (Зохиогч), Cong-Jian Xu (Зохиогч)
• Формат: Ном
• Хэвлэсэн: Taylor & Francis Group, 2018-01-01T00:00:00Z.
• Нөхцлүүд: article
• Онлайн хандалт: Connect to this object online.

The distinct hormone molecules and receptors, such as follicle-stimulating hormone receptor (FSHR) in ovarian cancer, provide opportunities for more precisely targeted therapy. We previously developed FSHR-mediated nanoparticles and found that FSH peptides on the surface of nanoparticles improved th...